A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Adult Participents With Major Depressive Disorder

Clinical trial NCT07101120 · COMPLETED

Trial details

NCT number: NCT07101120
Sponsor: Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder (MDD)

Start date: 2025-03-19
Primary completion: 2026-02-09
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.